That does not seem so strange to me. Fair valuation of biological assets is up by $67 million, only last year it was a bit more ie $83 million. Thus the difference is a decline of 20%. However the assets are up in aggregate and NTA is up by 19%.
Results in line with forecast, page-8
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)